Homepage

http://www.spectrumpharm.com/

Infos

http://finance.yahoo.com/q/ks?s=SPPI

Presentation

http://www.spectrumpharm.com/presentations/corporate/index.html

 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Spectrum Development Pipeline/Portfolio

Spectrum has a broad and diversified portfolio of proprietary drugs in various stages of development in the fields of oncology and urology.

Zevalin® (ibritumomab tiuxetan), an FDA-Approved, Proprietary, Biological Drug for Non-Hodgkin's Lymphoma. Fusilev™ (Levoleucovorin) for injection approved by the FDA on March 7, 2008.

EOquin® (Apaziquone), our lead development candidate, is a synthetic Bio-reductive prodrug that is being investigated in the treatment of non-invasive bladder cancer, and began two Phase 3 studies in 2007.

Spectrum also has three drugs in the Phase 2 stage of development: Ozarelix, for the treatment of prostate cancer and benign prostatic hypertrophy, Ortataxel, for the treatment of taxane-refractory tumors, and Satraplatin, a Phase 2 oral, anti-cancer drug, being investigated for non-small cell lung cancer (NSCLC).

The Company has three drugs in the Phase 1 stage of development: SPI-1620, an adjunct to chemotherapy, Elsamitrucin, which will target advanced solid tumors and Lucanthone, a chemotherapy sensitizer in the treatment of recurrent, malignant brain tumors.

Other drugs in development include RenaZorb™, used in the treatment of hyperphosphotemia in end stage renal disease (ESRD), and SPI-205 for chemotherapy induced neuropathy.

 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Fusilev: http://www.fusilev.com/

EOquin : http://www.spectrumpharm.com/eoquin.html 

 - video explanation of MoA - http://www.videojug.com/expertanswer/bladder-cancer-treatment-2/how-will-eoquin-work

Zevalin: http://www.zevalin.com/

- Study Suggests New Options for Follicular Lymphoma - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38001267

- NY Times on Zevalin under-usage - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38001196

- www.ONCBIZ.com - Radiopharmaceuticals Need a Jump-STaRT - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38001298

 --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Charting